Stay updated on Nalbuphine ER in IPF for Cough Clinical Trial
Sign up to get notified when there's something new on the Nalbuphine ER in IPF for Cough Clinical Trial page.

Latest updates to the Nalbuphine ER in IPF for Cough Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe web page has been updated to include new results from a clinical study on Nalbuphine ER tablets for treating cough in patients with Idiopathic Pulmonary Fibrosis (IPF), detailing the study's design, participant dosing, and assessment methods. Additionally, the number of study locations has been revised from 15 to 11.SummaryDifference100%
- Check20 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference2%
- Check27 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now indicates that results have been submitted, replacing the previous message that no results were posted.SummaryDifference0.1%
- Check48 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check62 days agoChange DetectedThe web page has undergone significant changes in the description of a clinical study involving Nalbuphine for treating cough in Idiopathic Pulmonary Fibrosis, with updates to the study design and collaborators.SummaryDifference24%
- Check70 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
Stay in the know with updates to Nalbuphine ER in IPF for Cough Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nalbuphine ER in IPF for Cough Clinical Trial page.